HOORAY
FOR SAVINGS
WHEN IT COMES TO SAVINGS YOU HAVE OPTIONS
WHEN IT COMES TO SAVINGS YOU HAVE OPTIONS
FIRST PRESCRIPTION
UPON ENROLLMENT
for commercially insured patients*
FIRST PRESCRIPTION
UPON ENROLLMENT
for commercially insured patients*
For 90-days (or 30-days)
For 90-days (or 30-days)
SUBSEQUENT
PRESCRIPTION
for commercially insured patients*
SUBSEQUENT
PRESCRIPTION
for commercially insured patients*
Patients save up to:
$750 per fill on 90-days prescription
$250 per fill on 90-days prescription
Patients save up to:
$750 per fill on 90-days prescription
$250 per fill on 90-days prescription
PATIENT
ASSISTANT
PROGRAM
PATIENT ASSISTANT
PROGRAM
To learn more
call 1-800-277-2254
or Visit
www.PAP.Novartis.com
To learn more
call 1-800-277-2254
or Visit
www.PAP.Novartis.com
On average, patients paid $45 for 90-days (or $15 per month) for OTC artificial tears.†
Patient Assistance Program
If you are experiencing financial hardship, and have limited or no prescription coverage, you may receive your medications for free.
*Limitations apply. Eligible, commercially-insured patients using the Copay Card pay $0 for their first prescription of Xiidra of up to 90-days. After the first fill, eligible, commercially-insured patients may pay as little as $0 for prescription of Xiidra, subject to a maximum monthly savings of $250 for a 30-day prescription and $750 for 90-day prescription. Offer not valid under Medicare, Medicaid, or any other federal or state program. Novartis reserves the right to rescind, revoke, or amend this program without notice. See complete Terms & Conditions for details.
†Based on average dollars per month spent on over-the-counter dry eye products by patients active in both the IQVIA LRx and OTC databases (n=2,258,782). Eligible patients must have at least one record of prescription activity (from any market) in the LRx database prior to the look-back period and at least one record of OTC activity. Calculation was completed by IQVIA based on the study period from November 2018 to October 2019.